After the Phase 1 data was back, arguably it wouldn’t have been a bad call to give doses for free and gamble on the efficacy even if it turned out to be below 50%.
The first two phases are the safety tests, the third one is efficacy (so we knew the vaccine was "safe" after phase 2, we just didn't know the efficacy - that's what the poster above is alluding to).